Researchers launch major study to unravel rare eye disease
NCT ID NCT05153057
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 600 people with birdshot chorioretinopathy, a rare inflammatory eye disease, to better understand its features and causes. Researchers will use imaging, vision tests, and quality-of-life surveys to track the disease over time. They will also analyze DNA to find genetic factors linked to the condition. No new treatments are being tested; the goal is to gather knowledge that could guide future research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIRDSHOT CHORIORETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ophtalmopôle, Hôpital Cochin
RECRUITINGParis, Île-de-France Region, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.